Cargando…
Rhabdoid Tumor: Gene Expression Clues to Pathogenesis and Potential Therapeutic Targets
Rhabdoid tumors (RT) are aggressive tumors characterized by genetic loss of SMARCB1 (SNF5, INI-1), a component of the SWI/SNF chromatin remodeling complex. No effective treatment is currently available. This study seeks to shed light on the SMARCB1-mediated pathogenesis of RT and to discover potenti...
Autores principales: | Gadd, Samantha, Sredni, Simone Treiger, Huang, Chiang-Ching, Perlman, Elizabeth J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868345/ https://www.ncbi.nlm.nih.gov/pubmed/20212451 http://dx.doi.org/10.1038/labinvest.2010.66 |
Ejemplares similares
-
Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
por: Sredni, Simone Treiger, et al.
Publicado: (2017) -
A Parallel Study of mRNA and microRNA Profiling of Peripheral Blood in Young Adult Women
por: Sredni, Simone T., et al.
Publicado: (2011) -
Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB)
por: Bailey, Anders W., et al.
Publicado: (2018) -
Human Malignant Rhabdoid Tumor Antigens as Biomarkers and Potential Therapeutic Targets
por: Hua, Timothy, et al.
Publicado: (2022) -
NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
por: Phi, Ji Hoon, et al.
Publicado: (2019)